BMEA
BMEA
NASDAQ · Biotechnology

Biomea Fusion Inc

$1.22
+0.08 (+7.02%)
As of Feb 8, 2:13 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 19.42M 19.36M 17.02M
Net Income -2,266,322 -2,263,432 -1,770,857
EPS
Profit Margin -11.7% -11.7% -10.4%
Rev Growth +9.6% -8.7% +9.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 36.01M 43.94M 35.70M
Total Equity 28.41M 25.31M 25.85M
D/E Ratio 1.27 1.74 1.38
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -3,805,934 -3,485,255 -2,994,447
Free Cash Flow -1,809,844 -1,626,073 -1,604,802